Skip to content

4Accepted Apr 13, 4:40 PM ET

ANI Pharmaceuticals Meredith Cook (Sr. VP, GC & Sec) Sells 500 Shares

ANIPANI PHARMACEUTICALS INC

Accepted (ET)

4:40 PM

Apr 13, 2026

Filed

Apr 13, 2026

Documents

1

Size

5.1 KB

Summary

ANI Pharmaceuticals Meredith Cook (Sr. VP, GC & Sec) Sells 500 Shares

Updated

What Happened Meredith Cook, Senior Vice President, General Counsel and Secretary of ANI Pharmaceuticals (ANIP), sold 500 shares on April 13, 2026. The shares were sold at $77.95 per share for a total transaction value of $38,975. This was a sale (not a purchase), and the filing notes the sale was executed pursuant to a Rule 10b5-1 trading plan.

Key Details

  • Transaction date and price: April 13, 2026 — 500 shares at $77.95 each.
  • Total value: $38,975.
  • Method: Reported as an open-market or private sale; footnote confirms it was effected under a 10b5-1 trading plan adopted September 15, 2025.
  • Shares owned after transaction: Not disclosed in the provided Form 4.
  • Filing timeliness: Report filed the same day (period and filing date 2026-04-13); no late filing indicated.

Context

  • Sales under a pre-established 10b5-1 plan are typically automatic and scheduled, so they do not necessarily signal a change in the insider’s view of the company. This report documents a routine insider sale rather than a purchase or option exercise.

AI-written summary · check the filing